Last updated 2026-07-27
TL;DR
Dapsone doesn't come as an injection. It's a topical gel (Aczone 5%/7.5%) applied to acne-prone skin, or an oral tablet used for conditions like dermatitis herpetiformis and leprosy. If you're seeing "injection sites" in search results, you're likely conflating it with other drugs or looking for application sites on skin. Oral dapsone requires G6PD testing before you ever take a dose.
Is dapsone available as an injection?
No. There is no FDA-approved injectable form of dapsone sold in the United States. Dapsone comes in exactly two forms: an oral tablet (25 mg and 100 mg, generic and brand names like Aczone are actually topical, not oral, more on that below) and a topical gel/cream applied to skin [1]. The oral tablet form is manufactured by companies like Jacobus Pharmaceutical and is approved for dermatitis herpetiformis and for multibacillary leprosy (Hansen's disease) as part of combination therapy [2]. The topical form, sold as Aczone 5% and Aczone 7.5% gel, is approved for acne vulgaris in patients 9 years and older [3]. So if you searched "dapsone injection sites," you're probably looking for one of three things: where to apply topical dapsone gel on your face, whether oral dapsone pills can be crushed or given some other way, or you've mixed dapsone up with an injectable drug that has a similar-sounding name or use case (some antibiotics and biologics for skin conditions are injectable, dapsone just isn't one of them). We'll cover all three below. Nobody makes an injectable dapsone product for dermatology or infectious disease use in the US or, as far as we can find in FDA and WHO documentation, anywhere else. If a compounding pharmacy or overseas seller offers you an "injectable dapsone," that is not a recognized, tested product. Treat it as a red flag, not a shortcut.
Where do you apply topical dapsone gel (the real "sites" question)?
Topical dapsone (Aczone) goes on clean, dry skin wherever acne lesions appear, typically the face, and sometimes the chest, back, or shoulders if those areas are affected and your prescriber approves it. A pea-sized amount usually covers the whole face once daily [3]. The application "sites" that actually matter here are: face (forehead, cheeks, chin, jawline), and less commonly trunk acne areas. You rub it in gently, let it dry, and don't layer it under makeup until it's absorbed. Most people apply it once a day, at night or morning depending on their regimen, after washing with a gentle cleanser. One quirk worth knowing: applying benzoyl peroxide at the same time or same site as dapsone gel can cause a temporary yellow-orange skin discoloration. It's cosmetic and washes off, not a chemical reaction to worry about. But it surprises people, so many dermatologists recommend applying the two products at different times of day rather than stacking them at the identical site simultaneously [3]. For exact dosing frequency and how much to use per application, see the Dapsone Rx dosage calculator. If you're wondering how long a tube lasts and how it should be stored between uses, check Dapsone Rx storage and shelf life and does Dapsone Rx need to be refrigerated (short answer: no, room temperature is fine for the gel).
Could you be thinking of a different injectable drug?
It happens a lot. Searches for "dapsone injection sites" often actually belong to a different drug entirely, especially other treatments prescribed for skin or autoimmune conditions that dapsone is sometimes confused with because they treat overlapping conditions (dermatitis herpetiformis, severe acne, autoimmune blistering diseases). Biologic injectables for skin conditions (like those used for psoriasis or hidradenitis suppurativa) are self-injected subcutaneously, usually in the abdomen or thigh, rotating sites to avoid irritation. That rotation advice is real and important. It's just not about dapsone. If your dermatologist mentioned both a topical or oral dapsone regimen and a separate injectable medication in the same visit, those are two different prescriptions with two different administration routes. Don't assume the injection instructions apply to your dapsone tablets or gel, and don't assume the dapsone warnings (G6PD testing, methemoglobinemia monitoring) apply to an unrelated biologic. Ask your prescriber to write down which instructions go with which drug if you're at all unsure. Medication mix-ups around administration route are a genuinely common and preventable error.
Can oral dapsone tablets be given by injection instead of swallowed?
No, and you shouldn't try. Oral dapsone tablets are formulated for gastrointestinal absorption. There's no clinical protocol, FDA-approved preparation, or safety data for injecting dissolved dapsone tablets, and doing so risks unpredictable dosing, infection at the injection site, and reactions the drug was never tested for. Oral dapsone already carries serious, well-documented risks when taken as intended: hemolytic anemia, methemoglobinemia, agranulocytosis, and dapsone hypersensitivity syndrome (a severe, sometimes fatal reaction with fever, rash, and organ involvement that can appear anywhere from 2 to 6 weeks after starting the drug) [4] [2]. None of that risk profile changes for the better by altering the route of administration. Improvising a delivery method just removes the dosing precision that makes the oral form manageable in the first place. If a prescriber has you on oral dapsone, take it exactly as prescribed, as a swallowed tablet, with the monitoring schedule they set (typically baseline and periodic CBC to watch for anemia and agranulocytosis, plus liver function checks) [2].
Why does oral dapsone require G6PD testing before you start?
Because dapsone causes oxidative stress on red blood cells, and people with glucose-6-phosphate dehydrogenase (G6PD) deficiency lack the enzyme buffer that normally protects cells from that stress. In G6PD-deficient patients, oral dapsone can trigger severe, sometimes acute hemolytic anemia [4]. The FDA label for oral dapsone states that patients should be tested for G6PD deficiency before starting therapy, and the dose should be reduced or the drug avoided in those with deficiency [2]. G6PD deficiency is not rare: it affects an estimated 400 million people worldwide and is more common in people of African, Mediterranean, Middle Eastern, and Southeast Asian descent, with X-linked inheritance meaning it's more frequently expressed in males [5]. This is a one-time blood test, inexpensive and widely available, and it is not optional in any responsible prescribing workflow for oral dapsone. If your prescriber didn't mention it, ask. For the fuller list of who should avoid oral dapsone altogether or use extra caution, see Dapsone Rx contraindications. Topical dapsone gel carries a much smaller version of this same theoretical risk. The Aczone label notes that hemolysis has been reported rarely with topical use, and because systemic absorption is low, routine G6PD testing is not required for topical therapy the way it is for oral dapsone [3]. That said, some prescribers still test G6PD status in topical patients with a known family history or symptoms suggestive of hemolysis, out of caution rather than label requirement.
What's the real difference between topical and oral dapsone risk?
| FDA-approved use | Acne vulgaris, ages 9+ | Dermatitis herpetiformis, leprosy (combination therapy) | |
|---|---|---|---|
| G6PD testing required | Not required by label; low systemic absorption [3] | Required before starting [2] | |
| Hemolytic anemia risk | Rare, low systemic exposure | Well-documented, dose-related [4] | |
| Methemoglobinemia | Not established as a labeled risk | Documented adverse effect [2] | |
| Dapsone hypersensitivity syndrome | Not reported with topical use | Documented, can be fatal [4] | |
| Routine blood monitoring | Not required | CBC at baseline and periodically [2] | That table is the whole story in one place. If your acne treatment plan is Aczone gel, you are not signing up for the oral drug's risk profile. If a prescriber puts you on oral dapsone for a systemic condition, you are, and the monitoring plan needs to reflect that. |
The gap is large, and conflating the two is the single most dangerous mistake people make when researching this drug. Topical dapsone is absorbed at a fraction of oral blood levels, roughly 100 times lower systemic exposure in clinical pharmacokinetic comparisons, and oral dapsone's serious systemic risks (hemolysis, methemoglobinemia, agranulocytosis, hypersensitivity syndrome) show up rarely if at all with the topical gel [3] [4]. | Factor | Topical dapsone (Aczone 5%/7.5%) | Oral dapsone (tablets) |
What does dapsone hypersensitivity syndrome look like, and when does it show up?
Dapsone hypersensitivity syndrome (sometimes called sulfone syndrome) is a rare but serious reaction to oral dapsone, marked by fever, a widespread rash, and involvement of internal organs, most often the liver. It typically appears within 2 to 6 weeks of starting oral therapy, not immediately and not months later, which is part of why the early weeks of oral dapsone treatment call for closer attention [4]. Because the syndrome can progress quickly and has a reported mortality risk in a meaningful minority of cases, prescribers typically advise patients starting oral dapsone to report any new fever, rash, sore throat, or unusual fatigue right away rather than waiting for a scheduled follow-up [4] [2]. This is exclusively an oral-dapsone phenomenon in the literature. It is not a described risk of topical Aczone gel, again because systemic drug levels with the topical form are so much lower [3].
How is oral dapsone actually dosed, and does that affect injection-related confusion?
Oral dapsone for dermatitis herpetiformis typically starts low, often 50 mg per day, and is adjusted based on response and tolerability, while leprosy regimens follow WHO multidrug therapy protocols that combine dapsone with rifampicin and, for multibacillary disease, clofazimine [2] [6]. None of these regimens involve injection at any stage. They're oral, once-daily dosing schedules. Because dosing gets adjusted based on lab work and clinical response, and because the drug has a long half-life that affects how quickly levels build up or clear, understanding your specific schedule matters more than for many other medications. If you want the mechanics of how oral dosing intervals relate to how the drug is cleared from your system, see Dapsone Rx half life. For topical dapsone, dosing is simpler: once daily, a thin layer over affected skin, no titration schedule tied to blood levels. If you've seen instructional content about "how to inject" dapsone anywhere online, it is very likely describing a different drug's administration, mislabeled content, or in rare cases a compounding source operating outside standard practice. There's no legitimate FDA-reviewed injectable dapsone protocol to follow. For general technique questions people search alongside dapsone (often confused because of unrelated injectable acne or dermatology treatments), see Dapsone Rx how to inject, which addresses this confusion directly.
How should you actually start dapsone, topical or oral, the right way?
For acne, the standard, well-supported path is topical Aczone gel, prescribed after a normal dermatology visit, with no G6PD testing required for most patients and no injection involved anywhere in the process [3]. This is what the large majority of people searching for dapsone and acne actually need and actually get. For oral dapsone, prescribed for dermatitis herpetiformis, leprosy, or occasionally other conditions under specialist care, the sequence matters: G6PD testing first, baseline CBC and liver function tests, then a conservative starting dose with follow-up labs in the early weeks to catch anemia, methemoglobinemia, or early signs of hypersensitivity syndrome before they become dangerous [2] [4]. A provider-reviewed process matters here specifically because the testing and monitoring steps are easy to skip if you're getting oral dapsone from a source that doesn't ask the right questions first. Dapsone Rx connects patients with providers who review candidacy (including the G6PD conversation) before any prescription moves forward, with prescriptions filled through a licensed pharmacy partner rather than any unverified injectable or compounded product claiming to be dapsone.
What should you do if you were told to get "dapsone injections" somewhere?
Stop and ask for clarification before proceeding. Since no FDA-approved injectable dapsone product exists, an instruction to get "dapsone injections" almost certainly means one of: a mislabeled reference to a different injectable drug, confusion with topical application, or a source outside standard, tested pharmaceutical practice. Ask directly: what is the exact drug name, what is the FDA-approved route of administration for that drug, and can you see the product labeling or package insert. Legitimate oral dapsone comes as tablets with a printed insert referencing FDA-approved indications and the G6PD testing recommendation [2]. Legitimate topical dapsone comes as a gel in a labeled tube referencing Aczone or its generic name, with instructions for topical application only [3]. If neither of those matches what you were told to expect, that's a signal to get a second opinion from a licensed dermatologist or pharmacist before taking or applying anything.
Frequently asked questions
Is there an injectable form of dapsone for acne?
No. Acne is treated with topical dapsone gel (Aczone 5% or 7.5%), applied directly to skin once daily. There is no FDA-approved injectable dapsone product for acne or any other condition sold in the US [3].
Do you need a G6PD test before using dapsone gel?
Usually not. The Aczone label doesn't require routine G6PD testing because systemic absorption from the gel is low, and rare hemolysis cases reported with topical use haven't led to a testing mandate [3]. Some prescribers still test if you have a family history of G6PD deficiency, out of caution.
Why does oral dapsone require G6PD testing but topical doesn't?
Oral dapsone reaches much higher blood levels and causes well-documented, dose-related hemolytic anemia in G6PD-deficient patients, so the FDA label requires testing before starting oral therapy [2][4]. Topical gel's systemic absorption is far lower, so that specific risk hasn't been established at the same magnitude [3].
What is dapsone hypersensitivity syndrome and how soon does it appear?
It's a rare, serious reaction to oral dapsone involving fever, rash, and organ involvement (often the liver), typically appearing 2 to 6 weeks after starting the drug [4]. It is not a reported risk of topical dapsone gel. Any fever or rash after starting oral dapsone should be reported to your prescriber immediately.
Can you crush and inject oral dapsone tablets?
No. Oral dapsone tablets have no tested, FDA-approved injectable preparation or protocol. Doing this yourself risks unpredictable dosing, infection, and reactions the drug wasn't studied for, on top of the drug's existing risks of hemolysis and methemoglobinemia [2].
Where do you apply topical dapsone gel?
On clean, dry, acne-affected skin, most commonly the face, using about a pea-sized amount once daily. Some prescribers approve use on the chest or back for body acne. Let it dry before applying other products or makeup [3].
Is dapsone the same as biologic injections used for skin conditions?
No, they're different drug classes entirely. Biologics for conditions like psoriasis or hidradenitis suppurativa are self-injected under the skin at rotating sites. Dapsone (topical or oral) is applied to skin or swallowed, never injected. Confusing the two is a common but important mistake to avoid.
What conditions is oral dapsone actually approved to treat?
Oral dapsone is FDA-approved for dermatitis herpetiformis and, as part of combination therapy with rifampicin and clofazimine, for multibacillary leprosy (Hansen's disease) [2][7]. It is not FDA-approved as a first-line acne treatment; that role belongs to the topical gel.
How common is G6PD deficiency, and who is at higher risk?
An estimated 400 million people worldwide have G6PD deficiency, with higher prevalence among people of African, Mediterranean, Middle Eastern, and Southeast Asian descent. It's X-linked, so it's expressed more often in males [5]. This is why testing before oral dapsone matters broadly, more than for a small subgroup.
What monitoring is needed while on oral dapsone?
Baseline G6PD testing, plus baseline and periodic complete blood counts to catch hemolytic anemia or agranulocytosis, and liver function monitoring given the hypersensitivity syndrome risk. Frequency depends on your prescriber's protocol and your specific condition and dose [2].
Does benzoyl peroxide interact with topical dapsone at the application site?
It doesn't cause a dangerous interaction, but combining benzoyl peroxide and topical dapsone at the same time or site can cause temporary yellow-orange skin staining that washes off. Many dermatologists suggest applying them at different times of day to avoid the cosmetic issue [3].
Can you buy injectable dapsone online?
You shouldn't, and you likely can't get a legitimate one. No FDA-approved injectable dapsone exists, so any product marketed that way, especially from unverified or overseas sellers, falls outside standard, tested pharmaceutical practice and should be treated as a red flag, not a shortcut.
Sources
- FDA, Aczone (dapsone) gel, 7.5%, label (NDA 021794): Dapsone's only FDA forms are oral tablets and topical gel; no injectable form exists
- FDA, Dapsone Tablets USP prescribing information (NDA 017864), DailyMed record: Oral dapsone indications, G6PD testing recommendation, and monitoring requirements
- FDA, Aczone (dapsone) gel, 7.5%, label, DailyMed record: Topical dapsone dosing, application guidance, and benzoyl peroxide discoloration note
- StatPearls (NCBI Bookshelf), Dapsone Toxicity: Dapsone hypersensitivity syndrome timing, symptoms, and hemolysis/methemoglobinemia risk
- CDC, Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency: G6PD deficiency prevalence and higher-risk population groups
- World Health Organization, Guidelines for the diagnosis, treatment and prevention of leprosy: Multidrug therapy for leprosy combines dapsone with rifampicin and clofazimine, given orally